Bayer To Hold On To Consumer Health While It Deals With More Pressing Issues

With Bayer "badly broken in four places," now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company's structure can be considered.

Bayer cross night
• Source: Bayer

Breaking up is hard to do, for Bayer at least. As it watches its biggest OTC rivals go solo, Bayer has decided to hold onto its Consumer Health business.

A six-month long strategic review led CEO Bill Anderson to conclude that offloading Consumer Health right now won’t solve the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

People On The Move: Appointments At Kenvue, EFSA, FSE

 
• By 

A round-up of the latest people moves: Kenvue names APAC president; EFSA nominates executive director; Food Supplements Europe elects board.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By 

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

Valbiotis Launches Plant-Based Heart Health Supplement

 
• By 

Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.

SkinBioTherapeutics Raises Funds For Supplement Development And Launch

 
• By 

UK-based firm will use the capital to launch its AxisBiotix skin health supplements in Superdrug stores and to develop new product formats.

More from Business

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Stada CEO Has ‘Big Hopes’ For AI-Driven Personalized Healthcare

 
• By 

“Harnessing AI’s astounding abilities to improve people’s lives and relieve overburdened healthcare systems is one of the great opportunities of our time,” argues Stada CEO Peter Goldschmidt in the company's Health Report 2025.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By 

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.